However, in contrast to anti-hyperlycemic agents such as metformin, pioglitazone and peroxisome proliferator-activated receptor gamma (PPAR) agonists, which were particularly well studied in this matter, very few clinical studies concerning the effects of GLP-1R targeting therapeutics on alleviation of depressive symptoms in humans have been carried out so far [118, 119]
It is not intended for human consumption, diagnosis, treatment, cure, or prevention of any disease
May 5, 2026 GHK-Cu is available in cosmetic skincare formulations over the counter and through Research Use Only research peptide suppliers
A simulation from Wegovys manufacturer, Novo Nordisk, for example, found a savings of $85 million over five years for 100,000 patientsbut the current list price of Wegovy over that same period would run $8 billion, a huge discrepancy even if insurers do not pay full price